FindTrial
Sign In

Maternal Opthalmic blood flow is used as a predictor of severe pregnancy induced hypertension.

Maternal Opthalmic Artery Doppler at 19 to 23 + 0 weeks as a predictor of Pre-eclampsia - A Descriptive observational study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064446
Enrollment
41
Registered
2024-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O149- Unspecified pre-eclampsia

Interventions

Control Intervention1: nil: nil

Sponsors

Sagarika N Swamyself
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.singleton live gestation 2.Gestational age between 19 to 23+0 weeks 3.After obtaining informed written consent

Exclusion criteria

Exclusion criteria: 1.Chronic hypertensive and gestational hypertension 2.Diagnosed congenital anomalies 3.Known case of Cardiac diseases 4.Known case of thromboembolic disorders on T.Ecospirin 5.Ocular conditions like infections,trauma ,tumors

Design outcomes

Primary

MeasureTime frame
To examine the potential value of opthalmic artery Doppler at 19 to 23weeksTimepoint: To examine the potential value of opthalmic artery Doppler at 19 to 23weeks—

Secondary

MeasureTime frame
To reduce the maternal morbidity and decide the plan of managementTimepoint: 19 to 23 weeks—

Countries

India

Contacts

Public ContactDrMB Bellad

Jawaharlal Nehru Medical College

drsgnarayanaswamy@gmail.com9980420665

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026